Stock listing

Luye Pharma Group Ltd.

Selected listing: 2186 · HKEX · HKD · HK

Luye Pharma Group Ltd. (HKEX:2186), Health Technology. Latest release Sep 29, 2026: Interim Report 2026.

2186:HKEXHKDHKUpdated October 2, 2026

Ticker: HKEX:2186
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: HKEX
Currency: HKD

About Luye Pharma Group Ltd.

Luye Pharma Group Ltd. is a public company listed on the Hong Kong Stock Exchange under the ticker 2186. Luye Pharma focuses on the research, development, and commercialization of innovative pharmaceutical products.

Latest news from Luye Pharma Group Ltd.

Interim Report 2026

September 29, 2026

Luye Pharma : Announces 2026 Interim Results

September 1, 2026

Luye Pharma : Announces Successful Completion of a U.S. Bridging Clinical Trial of Its Innovative Drug LY03015 (VMAT2 Inhibitor/Sigma-1R ...

August 5, 2026

Luye Pharma : Announces Positive Phase 2 Results of LY03015, a VMAT2 Inhibitor and Sigma-1R Agonist, for Tardive Dyskinesia in China

June 16, 2026

Luye Pharma : Announces First Subject Enrolled in U.S. PK Bridging Clinical Trial of Its VMAT2 Inhibitor/Sigma-1R Agonist LY03015

April 21, 2026

All Luye Pharma Group Ltd. news →

Research Luye Pharma Group Ltd.

Luye Pharma Group Ltd. company profile

View the public company page for Luye Pharma Group Ltd. on 6ix.

Luye Pharma Group Ltd. news

Read company news and market updates connected to Luye Pharma Group Ltd..

Luye Pharma Group Ltd. investor events

Find investor webinars, events, and replay context for Luye Pharma Group Ltd..